John Glenn sold $1.5M of IRMD
CHIEF FINANCIAL OFFICER at IRADIMED CORP. 15,000 shares at an average of $97.29, traded Dec 11, 2025, filed Dec 12, 2025.
Score components
- +22RoleCFO
- +25Trade size$1.5M at market
- +20Share of holdings soldSold 67% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001253497-25-000015, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 11, 2025 | SOpen-market sale Common Stock | -14,468 | $97.26 | $1.4M | 7,894 | Dec 12, 2025 |
| Dec 11, 2025 | SOpen-market sale Common Stock | -532 | $98.09 | $52k | 7,362 | Dec 12, 2025 |
| Dec 11, 2025 | MOption exercise Common Stock | +1,812 | - | - | 9,174 | Dec 12, 2025 |
| Dec 11, 2025 | FTax withholding Common Stock | -714 | $97.38 | $70k | 8,460 | Dec 12, 2025 |
| Dec 11, 2025 | MOption exercise Restricted Stock Unitsderivative | -1,812 | $0.00 | $0 | 3,624 | Dec 12, 2025 |
Related signals
Other insiders at IRADIMED CORP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | IRMDsell IRADIMED CORP | Monty K Allen director | $123k 1,419 shares | -7% | |
| 25Weak | IRMDsell IRADIMED CORP | Monty K Allen director | $100k 1,000 shares | -5% | |
| 23Weak | IRADIMED CORP | Roger E. Susi CEO, PRESIDENT, CHAIRMAN | $488k 5,000 shares | -0% | |
| 38Weak | IRADIMED CORP | Roger E. Susi CEO, PRESIDENT, CHAIRMAN | $484k 5,000 shares | -0% | |
| 38Weak | IRADIMED CORP | Roger E. Susi CEO, PRESIDENT, CHAIRMAN | $484k 5,000 shares | -0% | |
| 44Moderate | IRADIMED CORP | James B Hawkins director | $290k 3,000 shares | -9% | |
| 38Weak | IRADIMED CORP | Roger E. Susi CEO, PRESIDENT, CHAIRMAN | $477k 5,000 shares | -0% | |
| 37Weak | IRADIMED CORP | Roger E. Susi CEO, PRESIDENT, CHAIRMAN | $464k 5,000 shares | -0% | |
| 37Weak | IRADIMED CORP | Roger E. Susi CEO, PRESIDENT, CHAIRMAN | $452k 5,000 shares | -0% | |
| 43Moderate | IRADIMED CORP | James B Hawkins director | $265k 3,000 shares | -9% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.